Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-1-5
pubmed:abstractText
1. The effect of bath application of sulphated cholecystokinin octapeptide (CCK-8) was studied on neurones in slices containing rat raphe nucleus. 2. Intracellular recordings were made from neurones in the dorsal raphe nucleus. Some of the neurones with the characteristics of 5-hydroxytryptamine (5-HT)-containing cells which were inhibited by 5-HT and excited by noradrenaline were excited by cholecystokinin. The response to cholecystokinin was dose-dependent over the range 10 to 1000 nM. 3. The response to CCK-8 persisted in the presence of tetrodotoxin. Either reduction of extracellular calcium or addition of 25 mM magnesium did not block the CCK response, suggesting it was mediated by receptors located on the membrane of the raphe neurones. 4. The agonist and antagonist specificity of the CCK response was determined. The CCKB selective agonist, pentagastrin, was inactive when applied at concentrations up to 10 microM. the CCKA receptor antagonist L-364,718 (1 to 100 nM) blocked the response to cholecystokinin. Much higher (1-10 microM) concentrations of the CCKB receptor antagonist L-365,260 were required for inhibition of the CCK response. 5. These data support the existence of a CCK receptor, located on raphe neurones in the rat, with a pharmacological profile very similar to that described for the CCKA type.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-2361176, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-2582271, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-2721567, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-2788717, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-3014520, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-3171686, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-3401640, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-3408996, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-3625281, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-3991051, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-6162516, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-6166350, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-6270603, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-6331598, http://linkedlifedata.com/resource/pubmed/commentcorrection/1364831-6987667
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
635-8
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain.
pubmed:affiliation
Parke-Davis Research Unit, Addenbrookes Hospital Site, Cambridge.
pubmed:publicationType
Journal Article, In Vitro